The global In Silico Clinical Trials Market is estimated to be valued at US$ 3,173.1 Mn in 2022 and is expected to exhibit a CAGR of 7.95% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Silico Clinical Trials are virtual trials conducted using computer models and simulations to evaluate drug efficacy and safety. These trials provide several advantages over traditional clinical trials, such as ... Read more
The In Silico Clinical Trials Market is estimated to be valued at US$ 3,410.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
In Silico clinical trials utilize computer simulation and mathematical modeling to simulate clinical trials without human participation. It helps replace, reduce and refine animal ... Read more
In silico clinical trials uses computer simulations and models to predict how a drug candidate might behave in actual human clinical trials. It provides evaluations of drug candidates and their effects in a simulated population without exposing real human subjects to risks. This reduces the time and costs involved in early phase clinical trials as drug candidates that do not meet the predefined criteria can be eliminated at a very early stage.
